Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
XORTX Therapeutics Inc
XRTXCurrent price
1.73 USD
-0.03 USD (-1.70%)
Last closed
1.75 USD
Company
www.xortx.com
ISIN
CA98420Q2071
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
5 139 301 USD
Yield for 12 month
-69.82 %
1Y
3Y
5Y
10Y
15Y
XRTX
XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, a program to treat acute kidney injury (AKI) associated with respiratory virus infection and associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. It has a collaboration and license agreements with the Icahn School of Medicine; and a license agreement with the University of Florida Research Foundation, Inc. The company is based in Alberta Beach, Canada. Address: 3710 ? 33rd Street NW, Alberta Beach, AB, Canada, T2L 2M1
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
12.13 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
-33 042 USD
Last Quarter
-31 988 USD
Key Figures XRTX
1 year
3 years
5 years
10 years
EBITDA
-3 303 909 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-33.14 %
PEG Ratio
–
Return On Equity TTM
-29.36 %
Wall Street Target Price
12.13 USD
Revenue TTM
–
Book Value
0.93 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.37 USD
Diluted Eps TTM
-0.37 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics XRTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History XRTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:9
Payout Ratio
–
Last Split Date
14.11.2023
Dividend Date
–
Stock Valuation XRTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
0.9621
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.0864
Price Book MRQ
1.9001
Financials XRTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators XRTX
For 52 weeks
1.09 USD
7.52 USD
50 Day MA
1.71 USD
Shares Short Prior Month
463
200 Day MA
2.53 USD
Short Ratio
0.17
Shares Short
1 230 917
Short Percent
43.52 %
BeatStart